Dublin, March 08, 2018 (GLOBE NEWSWIRE) — The “Research Antibodies and Reagents Market – Global Opportunity Analysis and Industry Forecast (2018-2023)” report has been added to ResearchAndMarkets.com’s offering.
Global research antibodies and reagents market is expected to reach USD 13,276.5 million by 2023, at a CAGR of 6.5% during the forecast period of 2018 to 2023.
Research antibodies and reagents are used concurrently during an experimental research for the development of protein, gene, or antigen specific drugs and biomarkers for rapid detection and diagnosis of chronic diseases.
The report carries out an impact analysis of the key industry drivers, restraints, opportunities, and challenges in the market dynamics segment. Rising proteomics and genomics research studies, increasing funding for research activities, and growing industry-academia collaborations are majorly driving the global research antibodies and reagents market. However, high cost and time related to development of potential antibodies hinders the growth of this market to some extent.
In addition, the report further gives an extensive outlook on various healthcare facilities served by the research antibodies and reagents. These industries include pharmaceutical and biotechnology industry, academic and research institutes, and contract research organizations.
These end user segments further briefly talks about the trends impacting the growth of these markets and the benefits involved with the use of research antibodies and reagents in these verticals to improve overall efficiency and outcomes of the research experiments for drug discovery and development.
Key questions answered in the report:
- Which are the high growth market segments in terms of product type, technology, applications, end users, and regions/countries?
- What is the historical market for research antibodies and reagents across the globe?
- What are the market forecasts and estimates from the period 2018-2023?
- What was the historical market for research antibodies and reagents?
- What are the major drivers, restraints, opportunities, and challenges in the global research antibodies and reagents market?
- Who are the major players in the global research antibodies and reagents market and what share of the market do they hold?
- Who are the major players in various countries and what share of the market do they hold?
- What are the competitive landscapes and who are the market leaders by sub-region in the global research antibodies and reagents market?
- What are the recent developments in the global research antibodies and reagents market?
- What are the different strategies adopted by the major players in the global research antibodies and reagents market?
- What are the geographical trends and high growth regions/ countries?
- Who are the local emerging players in the global research antibodies and reagents market and how do they compete with the global players?
Key Topics Covered:
1. Introduction
1.1. Market Ecosystem
1.2. Currency and Limitations
1.3. Key Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Insights
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Rising Proteomics and Genomics Research Studies
4.2.1.2. Increase in the Funding for Research Activities
4.2.1.3. Growing Industry-Academia Collaboration
4.2.1.4. Other Drivers
4.2.2. Restraints
4.2.2.1. High Cost and Time Related to Identification and Development of Potential Antibodies
4.2.2.1. Other Restraints
4.2.3. Opportunities
4.2.3.1. Growing Demand for Protein Therapeutics and Personalized Medicines
4.4.3.2. Rising Investment and Focus on Stem-Cell Research
4.4.3.3. Rising Need for New Biomarker Identification
4.2.3.4. Significant Opportunities from Emerging Asia-Pacific and Latin-American Markets
4.4.3.5. Other Opportunities
4.2.4. Challenges
4.2.4.1. Issues Related to Quality and Stability of Research Antibodies
4.2.4.2. Intense Pricing Pressure on Leading Players
4.2.4.3. Other Challenges
4.3. Market Share Analysis, by Key Players
5. Research Antibodies and Reagents Market, by Product
5.1. Introduction
5.2. Reagents
5.2.1. Media and Serum
5.2.2. Stains and Dyes
5.2.3. Probes
5.2.4. Buffers
5.2.5. Solvents
5.2.6. Enzymes
5.2.7. Proteins
5.2.8. Others
5.3. Antibodies
5.3.1. Antibodies Market, by Type
5.3.1.1. Primary Antibodies
5.3.1.2. Secondary Antibodies
5.3.2. Antibodies Market, by Production
5.3.2.1. Monoclonal Antibodies
5.3.2.2. Polyclonal Antibodies
5.3.2.3. Antibody Fragments
5.3.3. Antibodies Market, by Source
5.3.3.1. Mouse
5.3.3.2. Rabbit
5.3.3.3. Others
5.3.4. Antibodies Market, by Research Area
5.3.4.1. Oncology
5.3.4.2. Infectious Diseases
5.3.4.3. Cardiovascular Disease
5.3.4.4. Immunology
5.3.4.5. Neurology
5.3.4.6. Stem Cell
5.3.4.7. Others
6. Research Antibodies and Reagents Market, by Technology
6.1. Introduction
6.2. Western Blotting
6.3. Immunofluorescence
6.4. Immunosorbent Assays
6.5. Flow Cytometry
6.6. Immunohistochemistry
6.7. Immunoprecipitation
6.8. Others
7. Research Antibodies and Reagents Market, by Application
7.1. Introduction
7.2. Proteomics
7.3. Drug Discovery and Development
7.4. Genomics
8. Research Antibodies and Reagents Market, by End Users
8.1. Introduction
8.2. Pharmaceutical & Biotechnology Industry
8.3. Academic & Research Institutes
8.4. Contract Research Organizations
9. Research Antibodies and Reagents Market, by Geography
10. Competitive Landscape
10.1 Introduction
10.2. Approvals
10.3. Partnerships, Agreements, & Collaborations
10.4. Mergers & Acquisitions
10.5. New Product Launches
10.6. Expansions
11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
- GE Healthcare (U.S.)
- Merck & Co. Inc.(U.S.)
- Thermo Fisher Scientific Inc.(U.S.)
- Amgen Inc.(U.S.)
- Sanofi (France)
- F. Hoffmann La-Roche Ltd (Switzerland)
- Rockland Immunochemicals Inc.(U.S.)
- Johnson & Johnson (U.S.)
- Agilent Technologies Inc.(U.S.)
- Eli Lilly and Company (U.S.)
- Becton Dickinsonand Company (U.S.)
- Danaher Corporation (U.S.)
- PerkinElmer Inc.(U.S.)
- GenScript Biotech Corporation (U.S.)
- Lonza (Switzerland)
- Bio-Techne Corporation (U.S.)
- Bio-Rad Laboratories Inc.(U.S.)
- Teva Pharmaceutical Industries Limited (Israel)
- Santa Cruz Biotechnology Inc.(U.S.)
- BioLegend Inc.(U.S.)
- Abcam PLC (U.K.)
- Cell Signaling Technology Inc.(U.S.)
For more information about this report visit https://www.researchandmarkets.com/research/mfdgwq/2018_research?w=12
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Immune Disorders Drugs
